Defective regulatory and effector T cell functions in patients with FOXP3 mutations
Top Cited Papers
Open Access
- 1 June 2006
- journal article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 116 (6) , 1713-1722
- https://doi.org/10.1172/jci25112
Abstract
The autoimmune disease immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) is caused by mutations in the forkhead box protein P3 (FOXP3) gene. In the mouse model of FOXP3 deficiency, the lack of CD4+CD25+ Tregs is responsible for lethal autoimmunity, indicating that FOXP3 is required for the differentiation of this Treg subset. We show that the number and phenotype of CD4+CD25+ T cells from IPEX patients are comparable to those of normal donors. CD4+CD25high T cells from IPEX patients who express FOXP3 protein suppressed the in vitro proliferation of effector T cells from normal donors, when activated by “weak” TCR stimuli. In contrast, the suppressive function of CD4+CD25high T cells from IPEX patients who do not express FOXP3 protein was profoundly impaired. Importantly, CD4+CD25high T cells from either FOXP3+ or FOXP3– IPEX patients showed altered suppression toward autologous effector T cells. Interestingly, IL-2 and IFN-γ production by PBMCs from IPEX patients was significantly decreased. These findings indicate that FOXP3 mutations in IPEX patients result in heterogeneous biological abnormalities, leading not necessarily to a lack of differentiation of CD4+CD25high Tregs but rather to a dysfunction in these cells and in effector T cells.Keywords
This publication has 47 references indexed in Scilit:
- IFN-γ production by alloantigen-reactive regulatory T cells is important for their regulatory function in vivoThe Journal of Experimental Medicine, 2005
- Regulatory T cellsTransplantation and Cellular Therapy, 2005
- Expression of FOXP3 mRNA is not confined to CD4+CD25+ T regulatory cells in humansHuman Immunology, 2005
- Tolerance, not immunity, crucially depends on IL-2Nature Reviews Immunology, 2004
- Loss of Functional Suppression by CD4+CD25+ Regulatory T Cells in Patients with Multiple SclerosisThe Journal of Experimental Medicine, 2004
- Activation requirements for the induction of CD4+CD25+ T cell suppressor functionEuropean Journal of Immunology, 2004
- Conversion of Peripheral CD4+CD25− Naive T Cells to CD4+CD25+ Regulatory T Cells by TGF-β Induction of Transcription Factor Foxp3 The Journal of Experimental Medicine, 2003
- Control of Regulatory T Cell Development by the Transcription Factor Foxp3Science, 2003
- Interleukin 2 Signaling Is Required for CD4+ Regulatory T Cell FunctionThe Journal of Experimental Medicine, 2002
- Major difference in aetiology and phenotypic abnormalities between transient and permanent neonatal diabetesJournal of Medical Genetics, 2002